A354390 Stock Overview
Baskhanbio Pharma Inc. provides pain medicines before and after surgery, and medical devices for surgical process in South Korea.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
Baskhanbio Pharma Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₩7,390.00 |
52 Week High | ₩9,200.00 |
52 Week Low | ₩5,310.00 |
Beta | 0 |
1 Month Change | 5.57% |
3 Month Change | 19.19% |
1 Year Change | 19.19% |
3 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -37.37% |
Recent News & Updates
Recent updates
Shareholder Returns
A354390 | KR Pharmaceuticals | KR Market | |
---|---|---|---|
7D | -7.6% | 0.5% | -0.4% |
1Y | 19.2% | 7.1% | 4.5% |
Return vs Industry: A354390 exceeded the KR Pharmaceuticals industry which returned 7.1% over the past year.
Return vs Market: A354390 exceeded the KR Market which returned 4.5% over the past year.
Price Volatility
A354390 volatility | |
---|---|
A354390 Average Weekly Movement | 6.8% |
Pharmaceuticals Industry Average Movement | 4.6% |
Market Average Movement | 5.2% |
10% most volatile stocks in KR Market | 11.8% |
10% least volatile stocks in KR Market | 2.4% |
Stable Share Price: A354390 has not had significant price volatility in the past 3 months.
Volatility Over Time: A354390's weekly volatility has decreased from 13% to 7% over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
n/a | n/a | n/a | baskhanbio.com |
Baskhanbio Pharma Inc. provides pain medicines before and after surgery, and medical devices for surgical process in South Korea. The company is based in Anseong, South Korea.
Baskhanbio Pharma Inc. Fundamentals Summary
A354390 fundamental statistics | |
---|---|
Market cap | ₩51.86b |
Earnings (TTM) | ₩0 |
Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs A354390 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
A354390 income statement (TTM) | |
---|---|
Revenue | ₩0 |
Cost of Revenue | ₩0 |
Gross Profit | ₩0 |
Other Expenses | ₩0 |
Earnings | ₩0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
Earnings per share (EPS) | 0 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did A354390 perform over the long term?
See historical performance and comparison